These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11955970)

  • 1. Clinical and neuropsychological correlates of the P300 in schizophrenia.
    Nieman DH; Koelman JH; Linszen DH; Bour LJ; Dingemans PM; Ongerboer de Visser BW
    Schizophr Res; 2002 May; 55(1-2):105-13. PubMed ID: 11955970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N100 and P300 amplitude to Go and No-Go variants of the auditory oddball in siblings discordant for schizophrenia.
    Sumich A; Kumari V; Dodd P; Ettinger U; Hughes C; Zachariah E; Sharma T
    Schizophr Res; 2008 Jan; 98(1-3):265-77. PubMed ID: 18022352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of olanzapine on auditory P300 in schizophrenia.
    Gonul AS; Suer C; Coburn K; Ozesmi C; Oguz A; Yilmaz A
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):173-7. PubMed ID: 12551741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P300 and symptom improvement in schizophrenia.
    Gallinat J; Riedel M; Juckel G; Sokullu S; Frodl T; Moukhtieva R; Mavrogiorgou P; Nisslé S; Müller N; Danker-Hopfe H; Hegerl U
    Psychopharmacology (Berl); 2001 Oct; 158(1):55-65. PubMed ID: 11685384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
    Feldman PD; Kaiser CJ; Kennedy JS; Sutton VK; Tran PV; Tollefson GD; Zhang F; Breier A
    J Clin Psychiatry; 2003 Sep; 64(9):998-1004. PubMed ID: 14628974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P300 alterations in schizophrenic patients experiencing auditory hallucinations.
    Papageorgiou C; Oulis P; Vasios C; Kontopantelis E; Uzunoglu N; Rabavilas A; Christodoulou GN
    Eur Neuropsychopharmacol; 2004 May; 14(3):227-36. PubMed ID: 15056482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State and trait markers of emotionally charged visual event-related potentials (P300) in drug-naïve schizophrenia.
    Mori K; Morita K; Shoji Y; Matsuoka T; Fujiki R; Uchimura N
    Psychiatry Clin Neurosci; 2012 Jun; 66(4):261-9. PubMed ID: 22624730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological correlates of P300 abnormalities in patients with schizophrenia and obsessive-compulsive disorder.
    Kim MS; Kang SS; Youn T; Kang DH; Kim JJ; Kwon JS
    Psychiatry Res; 2003 Jun; 123(2):109-23. PubMed ID: 12850250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study.
    Kasper S; Rosillon D; Duchesne I;
    Int Clin Psychopharmacol; 2001 Jul; 16(4):179-87. PubMed ID: 11459331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR; Mahmoud R
    Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auditory P300 event-related potentials and neuropsychological performance in schizophrenia and bipolar affective disorder.
    Souza VB; Muir WJ; Walker MT; Glabus MF; Roxborough HM; Sharp CW; Dunan JR; Blackwood DH
    Biol Psychiatry; 1995 Mar; 37(5):300-10. PubMed ID: 7748981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wisconsin Card Sort Test and P300 responses to novel auditory stimuli in schizophrenic patients.
    Merrin EL; Floyd TC; Deicken RF; Lane PA
    Int J Psychophysiol; 2006 Jun; 60(3):330-48. PubMed ID: 16143413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating cortical patterns of cognitive dysfunction in schizophrenia and posttraumatic stress disorder.
    Galletly CA; McFarlane AC; Clark R
    Psychiatry Res; 2008 May; 159(1-2):196-206. PubMed ID: 18423610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
    Bobes J; Rejas J; Garcia-Garcia M; Rico-Villademoros F; García-Portilla MP; Fernández I; Hernández G;
    Schizophr Res; 2003 Jul; 62(1-2):77-88. PubMed ID: 12765747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P300 and genetic risk for schizophrenia.
    Winterer G; Egan MF; Raedler T; Sanchez C; Jones DW; Coppola R; Weinberger DR
    Arch Gen Psychiatry; 2003 Nov; 60(11):1158-67. PubMed ID: 14609891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.
    Purdon SE; Jones BD; Stip E; Labelle A; Addington D; David SR; Breier A; Tollefson GD
    Arch Gen Psychiatry; 2000 Mar; 57(3):249-58. PubMed ID: 10711911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe.
    Salisbury DF; Shenton ME; Sherwood AR; Fischer IA; Yurgelun-Todd DA; Tohen M; McCarley RW
    Arch Gen Psychiatry; 1998 Feb; 55(2):173-80. PubMed ID: 9477932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auditory P300 in individuals clinically at risk for psychosis.
    Frommann I; Brinkmeyer J; Ruhrmann S; Hack E; Brockhaus-Dumke A; Bechdolf A; Wölwer W; Klosterkötter J; Maier W; Wagner M
    Int J Psychophysiol; 2008 Dec; 70(3):192-205. PubMed ID: 18700155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand.
    Gureje O; Miles W; Keks N; Grainger D; Lambert T; McGrath J; Tran P; Catts S; Fraser A; Hustig H; Andersen S; Crawford AM
    Schizophr Res; 2003 Jun; 61(2-3):303-14. PubMed ID: 12729882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.